Pharma industry experts indicate that strategy in 2026 is shifting to agentic AI, sustainable efficiency, and resilient supply chains to manage tariffs, regulations, and digitalization.

"The IRGC remains a potent force domestically" despite losses in the 12-day war with Israel, one Iran expert told Newsweek.

Man Utd place €35m proposal as Atlético weigh Marcos Llorente futureAtlético de Madrid have been presented with a decision ...

President Donald Trump promoted his efforts to boost U.S. manufacturing, as he tries to counter fears about a weakening job ...

Chip stocks rallied strongly in 2025 on AI and memory tailwinds. The Philadelphia Semiconductor index ($SOX) jumped more than ...

China and ASEAN as well as a crucial year for regional countries to promote the conclusion of the Code of Conduct (COC) in ...

Elon Musk is facing the fiercest backlash yet to his artificial intelligence ambitions, and he is not taking it quietly. As ...

The GoBruteforcer botnet is exploiting weak passwords on exposed servers to hunt crypto wallets and expand a growing malware ...

As e-commerce brands expand internationally, production location becomes a strategic lever. This article explores how local ...

Trump is the first president since Ronald Reagan in 1981 to try to dramatically change the national — and with it, the global ...